We are live on ! Find out more
AONC

American Oncology Network, Inc. Class A Common Stock
AONC

Delisted

AONC was delisted on the 7th of June, 2024.

Back to rankings

65 hedge funds and large institutions have $245M invested in American Oncology Network, Inc. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

7% more funds holding

Funds holding: 61 → 65 (+4)

1% less capital invested

Capital invested by funds: $246M → $245M (-$1.73M)

Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
16
Reduced
6
Closed
9
Calls
$472K
Puts
–
Net Calls
+$472K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
+$3.4M
2
CC
Centiva Capital
New York
+$2.79M
3
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$2.43M
4
SCM
Saba Capital Management
New York
+$2.02M
5
WCMNY
Westchester Capital Management (New York)
New York
+$1.88M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$3.42M
2
Blackstone Inc
Blackstone Inc
New York
-$2.44M
3
KLM
Kennedy Lewis Management
New York
-$1.95M
4
DCP
Diameter Capital Partners
New York
-$1.46M
5
AC
Athanor Capital
New York
-$1.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
1
Glazer Capital LLC
New York
$27.5M -$343K -35,324 -1%
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$14.8M +$1.53M +157,969 +12%
Millennium Management
3
Millennium Management
New York
$14.4M +$1.14M +117,708 +9%
Marshall Wace
4
Marshall Wace
United Kingdom
$13.2M +$50.5K +5,200 +0.4%
HSBC Holdings
5
HSBC Holdings
United Kingdom
$13M – – –
SCM
6
Saba Capital Management
New York
$11.7M +$2.02M +207,500 +21%
PC
7
Periscope Capital
Ontario, Canada
$10.1M -$4.86K -500 -0%
Goldman Sachs
8
Goldman Sachs
New York
$7.37M – – –
HI
9
HBK Investments
Texas
$7.32M – – –
Citadel Advisors
10
Citadel Advisors
Florida
$7.32M +$214 +22 +0%
SRF
11
Silver Rock Financial
California
$7.08M – – –
Hudson Bay Capital Management
12
Hudson Bay Capital Management
Connecticut
$6.3M – – –
CH
13
CVI Holdings
Delaware
$5.98M +$124K +12,736 +2%
RCM
14
Radcliffe Capital Management
Pennsylvania
$5.43M +$546K +56,227 +11%
ECP
15
Empyrean Capital Partners
California
$5.37M +$486K +50,000 +10%
DKCM
16
Davidson Kempner Capital Management
New York
$5.36M – – –
SC
17
Sculptor Capital
New York
$5.27M +$117K +12,086 +2%
Bank of Montreal
18
Bank of Montreal
Ontario, Canada
$4.89M – – –
FTCM
19
Fir Tree Capital Management
New York
$4.88M – – –
SFM
20
Soros Fund Management
New York
$4.88M – – –
WP
21
Woodline Partners
California
$3.9M – – –
WAM
22
Weiss Asset Management
Massachusetts
$3.52M – – –
LP
23
LMR Partners
United Kingdom
$3.43M +$12.6K +1,299 +0.4%
AIMCA
24
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$3.42M +$3.4M +350,000 New
CC
25
Centiva Capital
New York
$2.8M +$2.79M +287,097 New
1
2 3

AONC Hedge Fund Activity: Q1 2022 in Review

65 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q1 2022, worth a combined $245M — down 0.7% from $246M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AONC positions and 9 closed out — a net gain of 4 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was Alberta Investment Management Corp (AIMCo), opening a new position worth an estimated $3.4M. The largest seller was UBS O'Connor, exiting entirely with an estimated $3.42M sold.

  • 65 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q1 2022, up from 61 in Q4 2021.
  • Funds reported $245M of American Oncology Network, Inc. Class A Common Stock stock for Q1 2022, down 0.7% quarter-over-quarter.
  • 13 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q1 2022 and 9 closed out, a net change of +4 holders.
  • The largest American Oncology Network, Inc. Class A Common Stock buyer in Q1 2022 was Alberta Investment Management Corp (AIMCo), an estimated $3.4M added.
  • The largest American Oncology Network, Inc. Class A Common Stock seller in Q1 2022 was UBS O'Connor, an estimated $3.42M sold.

Based on aggregated 13F filings for Q1 2022.